Publication | Open Access

Design, synthesis and biological evaluation of fused naphthofuro[3,2-c] quinoline-6,7,12-triones and pyrano[3,2-c]quinoline-6,7,8,13-tetraones derivatives as ERK inhibitors with efficacy in BRAF-mutant melanoma

Medicinal ChemistryNatural Product SynthesisMedicineMelanomaBiological EvaluationAnti-cancer AgentErk InhibitorsPharmacologyRadiation OncologyTumor BiologyDrug DiscoveryBraf-mutant Melanoma